G01N2400/12 - CPC Classification Index

ClassID:

170694 ⎘

G01N2400/12 - CPC Classification

Classification description:

Assays, e.g. immunoassays or enzyme assays, involving carbohydrates; Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar

Sub-classes:

G01N2400/14 » alpha-D-Glucans, i.e having alpha 1,n (n=3,4,6) linkages between saccharide units, e.g. pullulan 12
G01N2400/24 » beta-D-Glucans, i.e. having beta 1,n (n=3,4,6) linkages between saccharide units, e.g. xanthan 47
G01N2400/32 » Galactans, e.g. agar, agarose, agaropectin, carrageenan 2
G01N2400/34 » alpha-D-Galacturonans, e.g. pectin 0
G01N2400/36 » beta-D-Fructofuranans, e.g. levan, insulin 2

Recent Application in this class:

20240002422

2024-01-04

Glycan Analysis and Profiling

20230194537

2023-06-22

COMPOUNDS FOR THE DETECTION OF GLYCANS

20230122455

2023-04-20

PROGNOSTIC MARKERS OF DISEASE RECURRENCE IN LIVER TRANSPLANT RECIPIENTS WITH HEPATOCELLULAR CARCINOMA

20220412985

2022-12-29

METHODS, COMPOSITIONS, AND KITS FOR HIGH-THROUGHPUT RELEASE, LABELING, AND ANALYSIS OF O-GLYCANS PRESENT ON A GLYCOCONJUGATE

20220396823

2022-12-15

Compositions, methods and treatments for inhibiting cell adhesion and virus binding and penetration

20220163549

2022-05-26

Glycan sample preparation

20210046479

2021-02-18

Devices and methods for detecting cancerous cells

20210017213

2021-01-21

Glycan Analysis and Profiling

20200371093

2020-11-26

Prognostic and Diagnostic Glycan-Based Biomarkers of Brain Damage

#10

20200174008

2020-06-04

Rapid fluorescence tagging of glycans and other biomolecules with enhanced MS signals

#11

20200003783

2020-01-02

Mass spectrometry imaging of glycans from tissue sections and improved analyte detection methods

#12

20190388447

2019-12-26

Glycan-based drugs, therapies and biomarkers

#13

20190227086

2019-07-25

Glycan sample preparation

#14

20190017095

2019-01-17

Compositions, methods and treatments for inhibiting cell adhesion and virus binding and penetration

#15

20180196060

2018-07-12

Mass spectrometry imaging of glycans from tissue sections and improved analyte detection methods

#16

20180143186

2018-05-24

KIT-OF-PARTS TO IDENTIFY MOTHER'S MILK MISSING FUCOSYLTRANSFERASE-2 DEPENDENT GLYCANS AND FEEDING DOSES WITH SAID GLYCANS

#17

20180120305

2018-05-03

Prognostic and diagnostic glycan-based biomarkers of brain damage

#18

20170305950

2017-10-26

GLYCAN ANALYSIS AND PROFILING

#19

20170205423

2017-07-20

Method of Mapping Glycans of Glycoproteins in Serum Samples

#20

20170045538

2017-02-16

Glycan sample preparation

#21

20160139136

2016-05-19

Rapid fluorescence tagging of glycans and other biomolecules with enhanced MS signals

#22

20160015729

2016-01-21

Glycan-based drugs, therapies and biomarkers

#23

20150338391

2015-11-26

In vitro diagnostic method for an invasive fungal infection using MALDI-TOFF mass spectrometry

#24

20150260720

2015-09-17

Method and kit for distinguishing between prostate carcinoma and benign prostatic hyperplasia

#25

20150212076

2015-07-30

Carbohydrate detection

#26

20150140598

2015-05-21

Methods of Screening Sulfated Polysaccharides for Therapeutic Activity for a Glycocalyx-Related Disease

#27

20150099669

2015-04-09

MASS SPECTROMETRY IMAGING OF GLYCANS FROM TISSUE SECTIONS AND IMPROVED ANALYTE DETECTION METHODS

#28

20140350263

2014-11-27

Rapid fluorescence tagging of glycans and other biomolecules with enhanced MS signals

#29

20140242709

2014-08-28

Rapid fluorescence tagging of glycans and other biomolecules with enhanced MS signals

#30

20140179011

2014-06-26

Rapid fluorescence tagging of glycans and other biomolecules with enhanced MS signals

#31

20140038215

2014-02-06

Derivatization of PNGase F released glycans on an HPLC chip

#32

20120329709

2012-12-27

PRODUCTION OF GLYCOPROTEINS

#33

20120245095

2012-09-27

Biglycan and related therapeutics and methods of use

#34

20120208722

2012-08-16

SURFACE ENHANCED RAMAN SPECTROSCOPY PLATFORMS AND METHODS

#35

20110257032

2011-10-20

MODULAR GLYCAN ARRAYS

#36

20110183910

2011-07-28

Biglycan and related therapeutics and methods of use

#37

20110177090

2011-07-21

Glycan markers and autoantibody signatures in HIV-1 and HIV-1-associated malignancies

#38

20110143373

2011-06-16

METHOD OF EVALUATING THE INTEGRITY OF THE PLASMA MEMBRANE OF CELLS BY DETECTING GLYCANS FOUND ONLY INTRACELLULARLY

#39

20110100816

2011-05-05

BLOOD SERUM MARKER FOR DETECTION AND DIAGNOSIS OF ALZHEIMER'S DISEASE

#40

20110085981

2011-04-14

Glycan-based drugs, therapies and biomarkers

#41

20110020941

2011-01-27

GLYCOSYLATION MARKERS FOR PANCREATITIS, SEPSIS AND PANCREATIC CANCER

#42

20100297609

2010-11-25

Vivo isotopic labeling method for quantitative glycomics

#43

20100279308

2010-11-04

RAPID LATERAL FLOW GLYCAN-DETECTING DEVICE

#44

20100178292

2010-07-15

CRYPTIC GLYCAN MARKERS AND APPLICATIONS THEREOF

#45

20100130405

2010-05-27

Biglycan and related therapeutics and methods of use

#46

20090317788

2009-12-24

Novel Carbohydrate Profile Compositions From Human Cells and Methods for Analysis and Modification Thereof

#47

20090162938

2009-06-25

Novel Carbohydrate Profile Compositions From Human Cells and Methods for Analysis and Modification Thereof

#48

20090104603

2009-04-23

Tissue carbohydrate compositions and analysis thereof

#49

20080274966

2008-11-06

Biglycan and related therapeutics and methods of use

#50

20080003180

2008-01-03

Aging biomarker

#51

20070059783

2007-03-15

Method of identifying markers diagnostic of disease and uses therefor in the diagnosis of cancer

#52

20050059580

2005-03-17

Biglycan and related therapeutics and methods of use